【Company Research】Termination of Coverage |
【Company Research】Termination of Coverage |
【Company Research】SF Holding (002352 CH) – Set to deliver strong earnings recovery in 2022E; U/G to BUY |
【Fixed Income Research】CSCHCN – Shenzhen SASAC to become the largest shareholder |
【行業研究】中國互聯網 – 元宇宙:數字經濟下一站 |
【Company Research】Kintor Pharmaceutical (9939 HK) – Continue to pursue the development of proxalutamide for treatment of COVID-19 |
【Company Research】Jinxin Fertility (1951 HK) – Core emphasis on provision of high quality medical services |
【Company Research】Jinxin Fertility (1951 HK) – Core emphasis on provision of high quality medical services |
【Company Research】Excellence Commercial Property (6989 HK) – Asset sale will not affect guidance |
【Company Research】I-Mab BioPharma (IMAB US) – Appointment of a globally renowned oncologist to lead the R&D organization |